Its potential strengths include a national professional accreditation programme, a structured surgical registry, extensive experience with laparoscopic gastrointestinal surgery, and clinical familiarity with metabolic disease occurring at lower BMI levels in Asian populations.
These factors do not mean that Korea is the right destination for every patient. Hospital quality, surgeon experience, procedure selection, medical risk, travel requirements, cost, and long-term follow-up should all be reviewed before treatment is arranged.
What Korea’s National Bariatric Surgery Registry Shows
A nationwide report from the Korean Society for Metabolic and Bariatric Surgery, or KSMBS, analysed 7,377 patients who underwent metabolic or bariatric surgery between 2019 and 2022.
The data were contributed by 68 KSMBS-certified surgeons at 58 institutions.
7,377
Patients analysed in the 2019–2022 KSMBS registry report.
58
Institutions contributing data to the registry.
68
KSMBS-certified surgeons contributing cases.
0
Deaths recorded in the registry during the four-year study period.
Across the study period:
- Sleeve gastrectomy accounted for approximately 71.1% to 78.9% of primary procedures.
- Roux-en-Y gastric bypass accounted for approximately 9.6% to 13.4%.
- Reported rates of leakage, bleeding, and obstruction after primary surgery were 0.5%, 0.9%, and 0.5%, respectively.
- No deaths were recorded in the registry during the four-year study period.
- Mean total weight loss at 12 months was approximately 27% across sleeve gastrectomy, Roux-en-Y gastric bypass, and Sleeve Plus groups.
These results describe patients included in the KSMBS registry and should not be interpreted as a guarantee of individual outcomes. Differences in patient selection, complication definitions, reporting systems, procedure type, and hospital experience limit direct comparisons with registries from other countries.
Source: Lee H, et al. A Nationwide Report on Metabolic and Bariatric Surgery in 2019–2022: Utilizing the Korean Society of Metabolic and Bariatric Surgery Database Registry. Journal of Metabolic and Bariatric Surgery. 2024;13(1):17–26.
Accreditation, Registry Reporting, and Multidisciplinary Care
Korea introduced national health insurance coverage for eligible bariatric and metabolic surgery patients in January 2019. During the same period, KSMBS expanded its surgeon and institutional accreditation system and electronic registry.
Only procedures performed by KSMBS-certified surgeons were eligible for inclusion in the registry analysed in the national report.
For an international patient, the important question is not simply whether a hospital is located in Korea. The treating institution should be evaluated individually for:
- Experience with the proposed procedure
- Surgeon accreditation and relevant case volume
- Anaesthesia and perioperative risk assessment
- Access to intensive and emergency care
- Endoscopy and diagnostic capacity
- Dietitian and metabolic follow-up
- Management of surgical complications
- Communication with the patient’s physician after returning home
We do not state that every NextWeight partner has JCI accreditation, specialist-hospital designation, halal meals, prayer facilities, or a specific digital hospital system. Where such features are relevant to your case, they are confirmed individually and shown on the relevant provider page.
Clinical Experience Relevant to Asian Patients
BMI alone does not fully describe metabolic risk.
Many Asian patients develop type 2 diabetes, hypertension, dyslipidaemia, fatty liver disease, or visceral adiposity at a lower BMI than is commonly observed in Western populations.
Korean bariatric and metabolic specialists therefore frequently evaluate the interaction between BMI, diabetes duration, glycaemic control, visceral fat, previous medication use, sleep apnoea, liver disease, and cardiovascular risk.
Treatment selection should not be based on ethnicity or BMI alone. Eligibility and procedure choice require individual assessment by a qualified specialist. We do not claim that Korea produces superior outcomes specifically because of Asian ethnicity; that would require a cited comparative study. Learn more in our guide to bariatric surgery for type 2 diabetes.
More Than One Surgical Option
Sleeve gastrectomy is the most frequently recorded primary bariatric procedure in Korea. Roux-en-Y gastric bypass and selected modified bypass procedures are also performed.
The appropriate procedure may depend on:
- BMI and weight history
- Type 2 diabetes and its duration
- Gastro-oesophageal reflux
- Previous abdominal surgery
- Endoscopic findings
- Nutritional risk
- Medication history
- The need for future gastric surveillance
- The patient’s ability to continue long-term follow-up
Sleeve Plus, one-anastomosis gastric bypass (OAGB), and robotic surgery are not universally superior. They are options used in selected patients, and only when offered by the treating institution. Compare the main procedures in our guides to sleeve gastrectomy and gastric bypass.
Metabolic surgery does not work simply by “naturally increasing GLP-1 and PYY.” It affects several physiological pathways, including gut hormones, bile acid signalling, appetite, insulin sensitivity, and nutrient transit. Our GLP-1 medication vs bariatric surgery review looks at how these approaches differ.
A Possible Treatment Pathway in Korea
The timeline below is illustrative. The actual schedule depends on the hospital, the procedure, and your clinical status.
Before travel
- Collection of medical history, medication list, previous weight-loss treatment, laboratory results, imaging, and endoscopy records
- Preliminary review by an appropriate hospital or specialist
- Discussion of likely tests, estimated cost, expected stay, and follow-up requirements
- Confirmation that travel should not be booked until the treating hospital has reviewed the available information
Days 1–3
- In-person consultation
- Blood tests and cardiopulmonary assessment
- Endoscopy or additional imaging where required
- Anaesthetic and nutritional assessment
- Final shared treatment decision
Treatment and admission
- The procedure and admission period depend on the hospital, procedure, and clinical status
- Surgery proceeds only after the treating team confirms eligibility and informed consent
Recovery in Korea
- Monitoring for pain, bleeding, leakage, dehydration, thromboembolism, infection, and difficulty tolerating fluids
- Gradual dietary progression according to the hospital’s protocol
- Discharge medication and nutritional supplementation education
- Review before clearance to fly
Estimated total stay
Most international surgical patients should plan approximately 10 to 21 days in Korea. The required stay may be longer depending on preoperative testing, procedure type, recovery, complications, or the treating hospital’s policy.
After returning home
- Surgical and metabolic follow-up
- Monitoring of hydration, nutritional intake, weight, glucose, and medication requirements
- Scheduled laboratory testing
- Vitamin and mineral supplementation
- Coordination with a local physician or emergency service when necessary
You can read more about the coordinated pathway in bariatric surgery in Korea and about long-term safety in our safety guide.
Communication and Individual Care Requirements
Clear communication is particularly important before and after metabolic surgery. Patients need to understand informed consent, medication changes, warning symptoms, hydration targets, dietary progression, supplementation, and emergency instructions.
NextWeight can help organise language support and communicate cultural, mobility, dietary, or religious requirements to the treating institution before travel.
Availability varies by hospital. Interpreter qualifications, halal meals, prayer rooms, accessible accommodation, airport transport, and nursing support must be confirmed for each individual case. We do not state that every patient is automatically assigned a government-certified interpreter or nurse.
Our Role, and Its Limits
- NextWeight is an information and coordination service, not a medical provider.
- NextWeight does not diagnose, prescribe, determine eligibility, or guarantee treatment.
- A preliminary review does not establish a doctor–patient relationship.
- Final treatment decisions are made by the treating licensed specialist.
- Costs, timing, facilities, and support services vary by institution.
- Emergency care after returning home must be accessed locally.
Frequently asked questions
Is bariatric surgery in Korea safe?
Korean registry data reported low rates of specific short-term complications and no recorded deaths among 7,377 patients included from 2019 to 2022. These population-level findings do not predict an individual patient’s risk.
How long should I stay in Korea after bariatric surgery?
Many international patients should plan approximately 10 to 21 days, although the treating hospital may recommend a shorter or longer period depending on testing, procedure type, and recovery.
Are Korean National Health Insurance prices available to international patients?
International patients generally should not assume that Korean National Health Insurance coverage applies. The hospital should issue an individual estimate after reviewing the case.
Can NextWeight decide whether I need surgery or GLP-1 medication?
No. NextWeight can help prepare information and coordinate specialist review, but diagnosis, prescribing, and treatment selection are performed by licensed clinicians.
Medical disclaimer
This page is general information, not medical advice, diagnosis, or treatment. The figures cited are from a population-level Korean registry and may not apply to any individual; they are not outcomes promised to any patient. Whether bariatric or metabolic treatment is appropriate can only be determined by a licensed specialist after full evaluation. NextWeight Korea, operated by DYPHI Inc., is a coordination and preliminary review support service and does not provide diagnosis, treatment, or surgical procedures directly.